FMA
STJ

FNY Managed Accounts’s St Jude Medical STJ Stock Holding History

FNY Managed Accounts’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40,529
Closed -$3.25M – 778
2016
Q4 		$3.25M Buy
40,529
+39,279
+3,142% +$3.12M 21.78% 2
2016
Q3 		$99.7K Buy
+1,250
New +$101K 0.08% 145
2015
Q1 		– Sell
-1,400
Closed -$91K – 480
2014
Q4 		$91K Buy
+1,400
New +$90.2K 0.11% 102

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

FNY Managed Accounts's STJ Position: Q1 2017 in Review

FNY Managed Accounts sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 40,529 shares — an estimated $3.25M sold.

FNY Managed Accounts first reported a position in STJ in Q4 2014 and held it in 3 quarters. The position peaked at $3.25M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • FNY Managed Accounts reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 40,529 St Jude Medical shares in Q1 2017, an estimated $3.25M.
  • FNY Managed Accounts first reported a position in St Jude Medical in Q4 2014 and held it in 3 quarters.
  • FNY Managed Accounts's St Jude Medical position peaked at $3.25M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on FNY Managed Accounts's 13F filing for Q1 2017, filed 15 May 2017.